Mendoza, Abdel Azis .
HRN: 21-47-01 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/16/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/16/2022
06/23/2022
IVTT
26mg
OD
Prematurity
Waiting Final Action
Indication: Prophylaxis Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes